[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"multiple-indications-cancer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:multiple-indications-cancer":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100615635","help-study---towards-high-throughput-and-efficient-long-axial-pet-with-oral-18ffdg-100615635",false,"NCT07295171","HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG","HELP","Inclusion Criteria:\n\n* Age ≥19 years\n* Participants who have received a standard of care \\[18F\\]FDG PET\u002FCT and are willing to undergo a study specific oral \\[18F\\]FDG PET\u002FCT within 2 weeks.\n\nExclusion Criteria:\n\nParticipant Inclusion Criteria\n\n* Age ≥19 years\n* Participants who have received a standard of care \\[18F\\]FDG PET\u002FCT and are willing to undergo a study specific oral \\[18F\\]FDG PET\u002FCT within 2 weeks.\n\nParticipant Exclusion Criteria\n\n* Pregnant or breast-feeding\n* Medically unstable (e.g., acute illness, unstable vital signs)\n* Urinary incontinence\u002Fcatheter.\n* Immobile, frail or vulnerable patients who cannot leave the department and would require an uptake room in any case.\n* Patients whose fasting blood sugar at the SOC PET was \\>11.0 mmol\u002Fl\n* Unable to swallow.\n* Patients with nasogastric tubes, percutaneous gastrostomy or other non-anatomical routes for nutrition.\n* Unable to lie flat for 1h (subset of participants - first 5 participants only).\n* Claustrophobia requiring medication.\n* Undergoing active treatment or assessment of an upper digestive tract tumor (stomach\u002Fesophagus)\n* Unable to provide written consent\n* Patients receiving biguanide anti-hyperglycemic agents (e.g. Metformin).\n* Insulin dependent diabetics.","ALL","19 Years",{"count":19,"type":20},27,"ESTIMATED","INTERVENTIONAL",[23],"NA","Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG. This study aims to assess the feasibility of a different method of administration - oral ingestion (rather than IV) of 18F-FDG through delayed imaging to identify the optimal time for scanning after consuming the drug. The study will aim to recruit 15-24 individuals who will receive two PET scans - one using delayed oral 18F-FDG imaging and a second regular 18F-FDG. The analysis will focus on establishing a suitable protocol for this administration route while considering patient preference and image quality.",[26,27,28],"Multiple Cancers","Multiple Indications Cancer","Feasibility Studies",[30,31,32,33,34],"Oral FDG","LAFOV","Long-axial Field-of-view Scanner","Quadra","Low-dose Oral Radiopharmaceuticals","RECRUITING","2026-03-26",{"date":38,"type":39},"2026-03-31","ACTUAL",{"date":41,"type":39},"2026-02-18",{"date":43,"type":20},"2027-02-18",{"name":45,"class":46},"British Columbia Cancer Agency","OTHER"]